HTGM Stock Price, Chart, Stats & News
HTG Molecular Diagnostics, Inc. (HTGM) does not currently pay a dividend.
HTGM chart
Fundamentals
Gross margin | 28.18% |
Operating margin | -327.19% |
Pretax margin | -339.03% |
Net margin | -339.20% |
Effective tax rate | -0.05% |
ROA | -121.47% |
ROE | -273.49% |
D/E | 0.90x |
Interest coverage ratio | -24.31x |
HTGM valuation
P/E | – |
P/S | 0.17x |
P/B | 7.92x |
P/CF | -2.32x |
P/FCF | -0.06x |
P/OCF | -2.32x |
PEG | -0.02x |
EV multiple | -0.42x |
About
Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targets. Their extensive portfolio features numerous molecular profiling panels, such as the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay (available in both EU and non-EU versions), HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq ALKPlus assay EU, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG immune response panel, and HTG mouse mRNA tumor response panel.
Similar securities
Based on sector and market capitalization
